CAS: 1229582-33-5
Ref: 7W-GW3144
1mg | 265.00 € | |
5mg | 454.00 € | |
10mg | 690.00 € |
Estimated delivery in United States, on Friday 10 May 2024
3-(1H-Indol-5-yl)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridine
CAS:1229582-33-5
Molecular weight:
421.54g/mol
Ref: 54-BISN0232
5mg | 116.00 € | |
25mg | 253.00 € | |
100mg | 597.00 € |
Estimated delivery in United States, on Friday 10 May 2024
Ref: 4Z-K-031084
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Friday 10 May 2024
URMC-099
CAS:1229582-33-5
URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19/42/14/150 nM, for MLK1/MLK2/MLK3/DLK), and …
Formula:
C27H27N5
Purity:
99.32%
Color and Shape:
Solid
Molecular weight:
421.54
- Inhibitors
- Angiogenesis
- Bcr-Abl
- Syk
- See more categories
- Cell Cycle/Checkpoint
- CDK
- ROCK
- Chromatin/Epigenetics
- DNA Damage/DNA Repair
- DNA Alkylation
- MAPK
- MEK
- MLK
- Metabolism
- SGK
- Neuroscience
- LRRK2
- Stem Cell and Derivatives
- Stem Cells
- Tyrosine Kinase/Adaptors
- Trk receptor
- VEGFR
- c-Met/HGFR
- Src
- IGF-1R
- Autophagy
- Aurora Kinase
- Cytoskeletal Signaling
Ref: TM-T6057
5mg | 56.00 € | |
10mg | 85.00 € | |
25mg | 138.00 € | |
50mg | 217.00 € | |
100mg | 371.00 € | |
1ml*10 (DMSO) | 58.00 € |
Estimated delivery in United States, on Friday 10 May 2024
URMC-099
Controlled ProductCAS:1229582-33-5
Applications URMC-099 is an orally bioavailable MLK3 inhibitor used in the treatment of Parkinson’s disease …
Formula:
C27H27N5
Color and Shape:
Pale Beige to Pale Brown Solid
Molecular weight:
421.54
Ref: TR-U842000
25mg | 773.00 € |
Estimated delivery in United States, on Thursday 13 Jun 2024
Ref: 3D-FU170951
1mg | To inquire | |
2mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire |
Estimated delivery in United States, on Friday 14 Jun 2024